- Advancing Collaborative Care of Multiple Myeloma With Bispecific ...🔍
- Optimizing the Use of Bispecific Antibodies in Myeloma and Beyond🔍
- Navigating Bispecific Antibodies for Multiple Myeloma🔍
- Prevention and Management of Bispecific Antibody Associated ...🔍
- Multiple Myeloma Resource Center🔍
- Bispecific Antibodies in Multiple Myeloma🔍
- Collaborating with Other Care Providers to Optimize Outcomes for ...🔍
- BCMA|Targeted Bispecific Antibodies Are 'Encouraging' for Some ...🔍
Advancing Collaborative Care of Multiple Myeloma With Bispecific ...
Advancing Collaborative Care of Multiple Myeloma With Bispecific ...
Transforming MM Management: Key Strategies for Infectious Disease Teams Using Bispecific Antibodies ... Bispecific antibodies (bsAbs) are a promising novel ...
Advancing Collaborative Care of Multiple Myeloma With Bispecific ...
Luis Nicolas Gonzalez Castro, MD, PhD. Assistant Professor of Neurology Harvard Medical School Brigham and Women's Hospital Dana Farber Cancer Institute
Optimizing the Use of Bispecific Antibodies in Myeloma and Beyond
... bispecific T-cell engagers in the realm of cancer, emphasizing the importance of community and tertiary care collaboration to handle unique ...
Navigating Bispecific Antibodies for Multiple Myeloma
... multiple myeloma (RRMM). In a Pharmacy Times Clinical ... Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment.
Prevention and Management of Bispecific Antibody Associated ...
This episode of Myeloma Matters features discussions of bispecific antibody therapy, a powerful form of targeted immunotherapy that has ...
Multiple Myeloma Resource Center - JADPRO Clinical Case Series
Coordination of Care for Patients With Heavily Pretreated Relapsed/Refractory Multiple Myeloma Receiving CAR T-Cell and Bispecific Therapies.
Bispecific Antibodies in Multiple Myeloma: Present and Future - PMC
... integrated into the multiple myeloma treatment paradigm in the near future. ... bispecific antibody EM801 for multiple myeloma treatment. Cancer Cell 2017 ...
Collaborating with Other Care Providers to Optimize Outcomes for ...
... multiple myeloma who are receiving treatment with bispecific antibodies navigate transitions of care to and from various healthcare settings.
BCMA-Targeted Bispecific Antibodies Are 'Encouraging' for Some ...
There are currently 3 FDA-approved bispecific antibodies in the relapsed/refractory multiple myeloma space: teclistamab (Tecvayli), elranatamab ...
Mechanisms of resistance to bispecific T-cell engagers in multiple ...
Bispecific T-cell engagers (TCEs) are revolutionizing patient care in multiple myeloma (MM). ... advanced disease and argue for their use in early ...
Role of Multidisciplinary Care in With MM Receiving Bispecific ...
Shared insight on the respective roles of a multidisciplinary care team involved in the management of multiple myeloma and associated ...
AbbVie Advances Oncology Pipeline With Start of Multiple Myeloma ...
... therapy. "Despite notable advances in treatment, most patients with multiple myeloma will eventually relapse. Patients with advanced disease ...
With New Bispecific Antibodies in Multiple Myeloma, Nurses Need ...
Elizabeth Aronson, MSN, FNP-BCN, OCN, discusses how the recent approvals of elranatamab and talquetamab are changing the treatment landscape ...
Optimizing Bispecific Antibody Therapy in Multiple Myeloma
The mission of the Academy of Oncology Nurse & Patient Navigators (AONN+) is to advance the role of patient navigation in cancer care and survivorship care ...
City of Hope — Developing Bispecific Antibody Therapies to ...
City of Hope is advancing novel immunotherapeutic modalities like bispecific antibody treatment to defeat multiple myeloma.
Bispecific Antibody Use in Patients With Lymphoma and Multiple ...
... management of antiCD20× CD3 BsAb toxicities mark a significant advancement. ... bispecific antibody for the treatment of multiple myeloma. Ben ...
Achieving Seamless Care Transitions With Patients Receiving ...
HematologyALL/AMLCLL/SLLGVHDHemophiliaMultiple Myeloma ... Payor-Provider Collaboration Driving Optimal Bispecific Therapy Strategies ...
Point-Counterpoint Bispecific Antibodies in Earlier Lines of Therapy ...
Bispecific antibodies (BsAbs) are the newest FDA approved class of therapy for patients with relapsed/refractory multiple myeloma whose disease has progressed ...
Bispecific Antibodies in Multiple Myeloma: Opportunities to Enhance ...
Bispecific antibodies represent a new treatment option for patients with myeloma. These antibodies activate the patient's own T-cells to kill their tumour ...
Oncology Nursing Considerations for Bispecific Antibodies in ...
The Nurse Navigator Role in Multiple Myeloma. Nursing education, management, and support have always been integral for optimal patient care. While the ...